Contribute Try STAT+ Today

Congressman Tom Price, President-elect Donald Trump’s nominee for secretary of health and human services, is doing what his prospective boss won’t: divesting financial interests in firms that could present a conflict of interest if he takes a role in the administration.

A letter dated Wednesday and addressed to an HHS ethics official lists 43 companies from which Price pledged to divest his interest within 90 days of his confirmation. Some, including Aetna, Amgen, Eli Lilly, and Pfizer, are major companies in the health care industry; others, including Amazon, Facebook, Delta Airlines, and Northrop Grumman, are not.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Has there been a follow-up on this story?
    I am really interested to know if/when he divested/resigned.

Comments are closed.